| AS-IDR-114-01 |
Therapeutic potential of de novo designed antimicrobial peptides against drug-resistant fungal infections |
Rita P-Y Chen |
Institute of Biological Chemistry |
2025/1/1~2028/12/31 |
| AS-IDR-114-02 |
Broad-Spectrum Bacteriophages for Antibiotic-Resistant Hospital-Acquired Infections |
Todd L. Lowary |
Institute of Biological Chemistry |
2025/1/1~2028/12/31 |
| AS-IDR-114-S07 |
Integrated Virome Surveillance and Functional Preparedness for Vector-Borne and Airborne Zoonotic Threats |
Shin Ru Shih |
Biomedical Translation Research Center, Institute of Biomedical Sciences, Genomics Research Center, National Pingtung University of Science and Technology, National Mosquito-Borne Diseases Control Research Center |
2025/5/1~2026/12/31 |
| AS-IDR-112-01 |
Optimize vaccine efficacy in susceptible populations and establish a cellular immunity evaluation platform |
Yungling Lee |
Institute of Biomedical Sciences, National Taiwan University |
2023/1/1~2026/12/31 |
| AS-IDR-112-02 |
Investigation of monkeypox virus to understand poxvirus invasion strategy for future preventive and therapeutic development |
Wen Chang |
Institute of Molecular Biology, Tzu Chi Hospital, National Defense Medical University Pre-Preventive Medicine Institute |
2023/1/1~2026/7/31 |
| AS-IDR-112-03 |
Structure-based peptide design to target conserved protein- protein interactions for disrupt viral replication |
Wei-Hau Chang |
Institute of Chemistry, Institute of Statistical Science |
2023/1/1~2026/12/31 |
| AS-IDR-113-01 |
Inhibition of ST6GAL1 abrogates the risk of coronavirus and influenza virus infection |
Chia-Wei Li |
Institute of Biomedical Sciences |
2024/1/1~2026/12/31 |
| AS-IDR-113-03 |
Breaking down the Achilles' heel of bacteria: comprehensively targeting Lipid II as a decisive battle |
Wei-Chieh Cheng |
Genomics Research Center, Agricultural Biotechnology Research Center, CHANG GUNG MEMORIAL HOSPITAL, National Taiwan University, National Sun Yat-sen University |
2024/1/1~2026/12/31 |